Detoxamin EDTA Time-Release Suppositories -Package Includes one free informational DVD. This package is medically equal to 5 IV chelation treatments at less than a third of the cost.  All Detoxamin Products are backed by a 100% satisfaction guarantee.

World Health Products, the developer of Detoxamin is the originator and developer of the EDTA time-release suppository technology. Our patented formula is unique and unlike any other. This is why Detoxamin is the only product of its kind that actually has the proof to back up its claims. Why is this important? Several reasons. Many companies promote better price, and product claims that have absolutely no scientific or clinical reference of any kind.

Detoxamin scientific proof of bioavailability and absorption superior to even that of IV Chelation therapy

Scientific evidence is important because all EDTA suppositories are not alike. Formulas, ingredients, consistency, time-release, and other important aspects that create high absorption of EDTA are all different. If you have used IV EDTA chelation before, you know absorption and bio-availability is the key to performance. If it's quality you are looking for, go with the proven leader - the one you can trust. Detoxamin, the only viable alternative to IV EDTA chelation in the world.

IV EDTA chelation, although very efficacious, is very expensive, invasive, time-consuming and inconvenient. All this puts this needed therapy out of reach for most people. Oral EDTA chelation products are poorly absorbed and Detoxamin fits today's lifestyle with its simple, convenient, gentle and efficient toxin removal. Our preferred chelation method of choice is due to the obvious convenience and affordability factor, but more importantly, to the extraordinary efficacy, safety and scientific validation through research.

Interim Report of Clinical Observations of the Effects with Detoxamin and Supportive Combination Therapy on Prostate Conditions

In an Institutional Review Board (IRB) approved study conducted at Tustin Longevity Center, thirty men between the ages of 48 to 74 exhibiting conditions of prostatitis, benign prostate hyperplasia, and prostate calcifications were enrolled in a 90-day clinical study. The interim trial examined the effects of a combination treatment of Detoxamin at 750mg given four times per week, Health Genesis vitamin/mineral complex given daily, one daily Natren's Healthy Trinity probiotic oil matrix capsule and tetracycline at 500mg given daily.

The initial 90-day observations revealed statistically significant Quality of Life (QOL) improvement in reducing the symptoms of benign prostate hyperplasia, with overall improvement in urinary conditions such as weak urinary stream, incomplete emptying of the bladder and strain upon urination. Results also showed a reduction of the frequency, intermittency and number of times the participants got up at night to urinate (nocturia). Erectile function was also improved in 27 out of 30 patients.

Toxic heavy metals were laboratory analyzed in packed red blood cells; the metals that showed statistically significant reductions were lead, cadmium and arsenic. Of the heavy metals analyzed in fecal samples, cadmium showed a significant decrease.

Blood chemistry panels were also analyzed in which high density lipids (HDL), the good cholesterol levels increased significantly over pre-treatment levels. The cholesterol to HDL ratios, low density lipids (LDL, bad cholesterol) and plaque 2 (LPPLA2), a marker that detects cardiovascular plaque significantly decreased in the majority of participants.

The researchers conducting this study are encouraged with the response to the treatment protocol for improving symptomology, removal of major toxic heavy metals and improving important cardiovascular markers with the men who are affected with debilitating prostate conditions. This study has been extended for an additional 90 days with some modifications of the protocol.

"With over seven years of medical chelation experience, I observed other toxic heavy metals such as aluminum, nickel, tungsten, uranium and beryllium and others being either decreased or excreted to large extents in my patients utilizing Detoxamin. This is extremely important for all people of all ages because of the abundance of continual toxic environmental exposure we all encounter each and every day. I am so confident of need for the removal of these metals with Detoxamin that I have chosen to devote my entire practice to instate the use of these suppositories in place of IV chelation with almost all my present and future patients. Detoxamin's gentle, safe and effective ability to remove these oxidatively damaging metals from our tissues is one of the single, most important things we can do to improve our health.

Heavy Metals and Chronic Fatigue

Chronic Fatigue is a disorder of unknown cause that lasts for prolonged periods and causes extreme and debilitating exhaustion as well as a wide range of other symptoms such as fever, headache, muscle ache and joint pain, often resembling flu and other viral infections. Also known as Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS), Chronic Epstein-Barr Virus (CEBV), Myalgic Encephalomyelitis (ME), "Yuppy Flu" and other names, it is frequently misdiagnosed as hypochondria, psychosomatic illness, or depression, because routine medical tests do not detect any problems. Chronic fatigue syndrome is exactly what its name implies, namely an overwhelming sense of fatigue. Symptoms may represent several ongoing disorders which begin abruptly, tend to come and go, and may last for 6 months. Because there are no specific laboratory tests, diagnosis is made by the presence of chronic fatigue that does not resolve. The clinical disorder is defined by fatigue severe enough to decrease daily activity by at least 50% for at least 6 months. In order to have this condition, it is necessary to eliminate all other clinical conditions, including possible psychiatric problems.

Please, Visit Heavy Metal Sources and Effects

Oxidative Stress and Chronic Fatigue Syndrome

Studies have shown that oxidative stress plays a role in the development of Chronic Fatigue Syndrome (Fulle et al. 2000; Richards et al. 2000; Logan et al. 2001). Oxidative stress is a term used to describe the body's prolonged exposure to oxidative factors that cause more free radicals than the body can neutralize. Free radicals are produced as a byproduct of normal metabolic functions. When there are enough free radical scavengers present, such as glutathione and vitamins C, E, and A, along with zinc and other nutrients, through normal metabolic functioning, the body will "mop up" or neutralize the free radicals. When free radicals are not neutralized, the body can become vulnerable to cellular destruction. A relationship between abnormal oxidative stress and Chronic Fatigue Syndrome can be found in the literature. An article in the journal Life Science described a study that showed that patients with Chronic Fatigue Syndrome had lower serum transferrin levels and higher lipoprotein peroxidation. These results indicate that patients with Chronic Fatigue Syndrome have increased susceptibility of LDL and VLDL to copper-induced peroxidation and that this is related both to their lower levels of serum transferrin and to other unidentified pro-oxidizing effects of Chronic Fatigue Syndrome (Manuel y Keenoy et al. 2001). Exercise has been shown to increase the production of oxidants. Fortunately, regular endurance exercise results in adaptations in the skeletal muscle antioxidant capacity, which protects myocytes (muscle cells) against the deleterious effects of oxidants and prevents extensive cellular damage (McCully et al. 1996; Powers et al. 1999). A study of the oxygen delivery to muscles in patients with Chronic Fatigue Syndrome found that oxygen delivery and oxidative metabolism was significantly reduced in Chronic Fatigue Syndrome patients after exercise (compared with sedentary controls) (McCully et al. 1999).

Metal Sensitivity and Chronic Fatigue Syndrome

The effect of dental metal (amalgam) removal was studied in 111 patients with metal hypersensitivity and symptoms resembling Chronic Fatigue Syndrome. After consultation with a dentist, the patients decided to replace their metal restorations with nonmetallic materials. A significant number of patients had metal-specific lymphocytes in the blood. Nickel was the most common, followed by inorganic mercury, gold, phenyl-mercury, cadmium, and palladium. As compared to lymphocyte responses in healthy subjects, the Chronic Fatigue Syndrome group had significantly increased responses to several metals, especially to inorganic mercury, phenyl-mercury, and gold. Following dental metal removal, 83 patients (76%) reported long-term health improvement; 24 patients (22%) reported unchanged health; and two patients (2%) reported worsening of symptoms. Following dental metal replacement, the lymphocyte reactivity to metals decreased as well (Stejskal et al. 1999) (see "Mercury Amalgam Toxicity" in the May 2001 issue of Life Extension Magazine).

HEAVY METALS & Cardiovascular Disease, High Blood Pressure, Angina,  Heart Disease,  Kidney Disease

Scientific & Clinical Advantages:
* The only EDTA suppository formula with bio-available studies
* High absorption and tissue concentration is proven in high tech lab analysis
* 2.5 million doses administered worldwide
* Currently involved in three IRB, FDA sanctioned studies
* The only EDTA suppository manufactured by an FDA approved GMP facility
* 2,500 doctors and clinicians worldwide use Detoxamin
* 50,000 patients and consumers have used Detoxamin
* Long lasting EDTA in system for deep heavy metal cleansing

 Other Advantages:
* 70% less than IV EDTA chelation therapy
* Non-invasive, no discomfort, no hassle
* No inconvenient, time consuming doctor visits
* Introduces less EDTA dosage, but lasts longer
* Safer than IV EDTA
* Decreases free radical damage caused by heavy metal toxins
* Well-tolerated by adults and children

 
Detoxamin Frequently Asked Questions